

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.78720168 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.78720168 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.70826499 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.62261337 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.52578961 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.52578961 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.52578961 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.52578961 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.52578961 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.52578961 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.96798753 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.91145204 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.86384865 |
| 14 | response to peptidoglycan (GO:0032494) | 4.85451040 |
| 15 | detection of other organism (GO:0098543) | 4.83240839 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.77852218 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 4.68830117 |
| 18 | cellular extravasation (GO:0045123) | 4.57747601 |
| 19 | detection of bacterium (GO:0016045) | 4.47543533 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.45998174 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44186787 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.39472266 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.38959875 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22577416 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.13232092 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.09673573 |
| 27 | microglial cell activation (GO:0001774) | 3.99992613 |
| 28 | leukocyte aggregation (GO:0070486) | 3.96171956 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94499845 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93793806 |
| 31 | neutrophil activation (GO:0042119) | 3.93086103 |
| 32 | detection of biotic stimulus (GO:0009595) | 3.88525940 |
| 33 | macrophage activation (GO:0042116) | 3.78192963 |
| 34 | respiratory burst (GO:0045730) | 3.76156848 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74931747 |
| 36 | response to host immune response (GO:0052572) | 3.70820064 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.70820064 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.68638247 |
| 39 | granulocyte activation (GO:0036230) | 3.66962804 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.61194837 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54526733 |
| 42 | response to interleukin-15 (GO:0070672) | 3.53991043 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51340571 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.48122625 |
| 45 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.48093190 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39392511 |
| 47 | response to host (GO:0075136) | 3.39392511 |
| 48 | response to host defenses (GO:0052200) | 3.39392511 |
| 49 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.35741617 |
| 50 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.34959479 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.33374710 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.28066377 |
| 53 | positive regulation of mast cell activation (GO:0033005) | 3.24154582 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.23525744 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.22969447 |
| 56 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22018054 |
| 57 | germinal center formation (GO:0002467) | 3.21373906 |
| 58 | negative thymic T cell selection (GO:0045060) | 3.21097414 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.20351537 |
| 60 | defense response to protozoan (GO:0042832) | 3.19540691 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.19497839 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.19497839 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.17610434 |
| 64 | response to type I interferon (GO:0034340) | 3.17580382 |
| 65 | * neutrophil mediated immunity (GO:0002446) | 3.16996290 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 3.15848339 |
| 67 | regulation of leukocyte degranulation (GO:0043300) | 3.15746301 |
| 68 | B cell receptor signaling pathway (GO:0050853) | 3.14694804 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 3.13453334 |
| 70 | negative T cell selection (GO:0043383) | 3.13104056 |
| 71 | regulation of mast cell activation (GO:0033003) | 3.10725369 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07777539 |
| 73 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07467067 |
| 74 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07440829 |
| 75 | regulation of B cell differentiation (GO:0045577) | 3.06917398 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.06146555 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06003772 |
| 78 | T cell migration (GO:0072678) | 3.04524762 |
| 79 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.03207209 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02836277 |
| 81 | dendritic cell migration (GO:0036336) | 2.98142471 |
| 82 | dendritic cell chemotaxis (GO:0002407) | 2.94697698 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 2.94027354 |
| 84 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93970374 |
| 85 | leukocyte degranulation (GO:0043299) | 2.93421072 |
| 86 | positive regulation of interferon-alpha production (GO:0032727) | 2.92977242 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91628254 |
| 88 | response to protozoan (GO:0001562) | 2.90658623 |
| 89 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87063971 |
| 90 | positive thymic T cell selection (GO:0045059) | 2.85283486 |
| 91 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85269747 |
| 92 | regulation of interferon-alpha production (GO:0032647) | 2.84138982 |
| 93 | myeloid leukocyte activation (GO:0002274) | 2.83466164 |
| 94 | B cell mediated immunity (GO:0019724) | 2.82707956 |
| 95 | tolerance induction (GO:0002507) | 2.81410323 |
| 96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.80604605 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80286903 |
| 98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.79055820 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 2.79055820 |
| 100 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.78667742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.58106071 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.70366485 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.09183167 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.90256283 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.73096489 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.62853604 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43241784 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.36250171 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98319632 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86168297 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84738227 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79670764 |
| 13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.75681667 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64684502 |
| 15 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.54184000 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.53000408 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50038563 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.44260467 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38142626 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.31476008 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28706940 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28418137 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.27392128 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22843040 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22516881 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20716552 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 2.14575936 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14229222 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.13332030 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11165834 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07122152 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03363898 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99054468 |
| 34 | * MYB_26560356_Chip-Seq_TH1_Human | 1.93341639 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93122986 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.85492239 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82504513 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.77592538 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76353053 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74448858 |
| 41 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63619653 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63064867 |
| 43 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62241474 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59093218 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54834312 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53166442 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.50764559 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49805399 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49477912 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46710487 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46169415 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45069314 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44798619 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41709324 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39970414 |
| 56 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.38422619 |
| 57 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37094238 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36327670 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35990195 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34939062 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25703454 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25316082 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24499632 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24333801 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22964571 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22864853 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22228944 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21765975 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21172491 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20552672 |
| 71 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18050381 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16861491 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16291034 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15425321 |
| 75 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13462848 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11440343 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09817880 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09067393 |
| 79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08790040 |
| 80 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08775827 |
| 81 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07883127 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05556125 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02861816 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02641841 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02512510 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99015883 |
| 87 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97576706 |
| 88 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.96522019 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96470609 |
| 90 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95610261 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95056485 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.94094685 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86287627 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85225001 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83212043 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83164025 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82849493 |
| 98 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79593584 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79566423 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79314636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.59591097 |
| 2 | MP0003303_peritoneal_inflammation | 4.10153557 |
| 3 | MP0003436_decreased_susceptibility_to | 3.95210436 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.58766351 |
| 5 | MP0002419_abnormal_innate_immunity | 3.03240933 |
| 6 | MP0009785_altered_susceptibility_to | 2.84475892 |
| 7 | MP0005671_abnormal_response_to | 2.80664404 |
| 8 | MP0006082_CNS_inflammation | 2.79932467 |
| 9 | MP0005025_abnormal_response_to | 2.77044049 |
| 10 | MP0001800_abnormal_humoral_immune | 2.73477035 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.71711381 |
| 12 | MP0000685_abnormal_immune_system | 2.68571801 |
| 13 | MP0001790_abnormal_immune_system | 2.61372042 |
| 14 | MP0005387_immune_system_phenotype | 2.61372042 |
| 15 | MP0002723_abnormal_immune_serum | 2.46108218 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.43681128 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.39324715 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.39120472 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.32688293 |
| 20 | MP0001819_abnormal_immune_cell | 2.30732621 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.30306792 |
| 22 | MP0005451_abnormal_body_composition | 2.12730688 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.08024270 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.06934673 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.03986229 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.03781534 |
| 27 | MP0002405_respiratory_system_inflammati | 1.92092646 |
| 28 | MP0008260_abnormal_autophagy | 1.86510376 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.81261101 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.80471360 |
| 31 | MP0003828_pulmonary_edema | 1.76408183 |
| 32 | MP0000716_abnormal_immune_system | 1.75736207 |
| 33 | MP0004947_skin_inflammation | 1.72125407 |
| 34 | MP0002398_abnormal_bone_marrow | 1.71067527 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.68790300 |
| 36 | MP0009764_decreased_sensitivity_to | 1.67175262 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.63296378 |
| 38 | MP0008469_abnormal_protein_level | 1.56984469 |
| 39 | MP0002132_abnormal_respiratory_system | 1.55414419 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.49563786 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.48427534 |
| 42 | MP0003075_altered_response_to | 1.45148718 |
| 43 | MP0002722_abnormal_immune_system | 1.44215029 |
| 44 | MP0009278_abnormal_bone_marrow | 1.44171629 |
| 45 | MP0004883_abnormal_blood_vessel | 1.40952422 |
| 46 | MP0003866_abnormal_defecation | 1.36562473 |
| 47 | MP0002429_abnormal_blood_cell | 1.36379060 |
| 48 | MP0005310_abnormal_salivary_gland | 1.33632722 |
| 49 | MP0003690_abnormal_glial_cell | 1.32107975 |
| 50 | MP0000858_altered_metastatic_potential | 1.32061812 |
| 51 | MP0004381_abnormal_hair_follicle | 1.31454313 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.30674970 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.29935843 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.29935843 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.27034906 |
| 56 | MP0004510_myositis | 1.26492882 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.23807754 |
| 58 | MP0001851_eye_inflammation | 1.22914819 |
| 59 | MP0005164_abnormal_response_to | 1.21808897 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.21231701 |
| 61 | MP0009840_abnormal_foam_cell | 1.19876236 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.19494822 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.19352368 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.16785013 |
| 65 | MP0000604_amyloidosis | 1.14647782 |
| 66 | MP0005166_decreased_susceptibility_to | 1.13778443 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.10475694 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.08392547 |
| 69 | MP0000343_altered_response_to | 1.03226968 |
| 70 | MP0001853_heart_inflammation | 0.95198323 |
| 71 | MP0008004_abnormal_stomach_pH | 0.94508349 |
| 72 | MP0009763_increased_sensitivity_to | 0.92935847 |
| 73 | MP0003448_altered_tumor_morphology | 0.89468771 |
| 74 | MP0001663_abnormal_digestive_system | 0.88006590 |
| 75 | MP0001873_stomach_inflammation | 0.81795379 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 0.80977957 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.80922039 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.80605687 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 0.77775699 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.75774320 |
| 81 | MP0002006_tumorigenesis | 0.75748107 |
| 82 | MP0003195_calcinosis | 0.75171951 |
| 83 | MP0005365_abnormal_bile_salt | 0.74526579 |
| 84 | MP0005390_skeleton_phenotype | 0.74277570 |
| 85 | MP0003252_abnormal_bile_duct | 0.72555511 |
| 86 | MP0003045_fibrosis | 0.72293980 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.72196050 |
| 88 | MP0000609_abnormal_liver_physiology | 0.71723487 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.71549254 |
| 90 | MP0000249_abnormal_blood_vessel | 0.70373923 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.69966247 |
| 92 | MP0004130_abnormal_muscle_cell | 0.69147348 |
| 93 | MP0002933_joint_inflammation | 0.68585389 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.67474627 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.66891099 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66223880 |
| 97 | MP0008874_decreased_physiological_sensi | 0.65268655 |
| 98 | MP0003795_abnormal_bone_structure | 0.63104582 |
| 99 | MP0003091_abnormal_cell_migration | 0.62792709 |
| 100 | MP0005376_homeostasis/metabolism_phenot | 0.58442588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.29189987 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.71691842 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.68374298 |
| 4 | Myositis (HP:0100614) | 5.62357074 |
| 5 | Orchitis (HP:0100796) | 5.42631362 |
| 6 | Optic neuritis (HP:0100653) | 5.19481631 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.19481631 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.18657835 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.13517487 |
| 10 | Stomatitis (HP:0010280) | 4.74796784 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47965013 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.99972386 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.99372153 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.97733611 |
| 15 | Recurrent skin infections (HP:0001581) | 3.84707464 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.81076385 |
| 17 | Obstructive lung disease (HP:0006536) | 3.66648376 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66648376 |
| 19 | Meningitis (HP:0001287) | 3.65730395 |
| 20 | Keratoconjunctivitis (HP:0001096) | 3.56109548 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53239314 |
| 22 | Encephalitis (HP:0002383) | 3.48062529 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.41155434 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.41152205 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.41152205 |
| 26 | Gingivitis (HP:0000230) | 3.39783976 |
| 27 | Vasculitis (HP:0002633) | 3.36163684 |
| 28 | Gingival bleeding (HP:0000225) | 3.25910323 |
| 29 | Urticaria (HP:0001025) | 3.22157745 |
| 30 | Increased IgE level (HP:0003212) | 3.17529549 |
| 31 | T lymphocytopenia (HP:0005403) | 3.10380728 |
| 32 | Pulmonary infiltrates (HP:0002113) | 3.06613733 |
| 33 | Amyloidosis (HP:0011034) | 3.05526530 |
| 34 | Hemoptysis (HP:0002105) | 3.04249782 |
| 35 | Abnormality of T cell number (HP:0011839) | 2.97867402 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.92322394 |
| 37 | Arterial thrombosis (HP:0004420) | 2.91206317 |
| 38 | Chest pain (HP:0100749) | 2.90766123 |
| 39 | Episodic fever (HP:0001954) | 2.86855757 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 2.85502768 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.83473100 |
| 42 | Pulmonary embolism (HP:0002204) | 2.83160623 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.80972650 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.80972650 |
| 45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.80972650 |
| 46 | Epistaxis (HP:0000421) | 2.78369940 |
| 47 | Leukocytosis (HP:0001974) | 2.76891143 |
| 48 | Pustule (HP:0200039) | 2.71490275 |
| 49 | Recurrent viral infections (HP:0004429) | 2.70555554 |
| 50 | Anorexia (HP:0002039) | 2.68295019 |
| 51 | Gangrene (HP:0100758) | 2.67972266 |
| 52 | Cellulitis (HP:0100658) | 2.66696069 |
| 53 | Hypochromic anemia (HP:0001931) | 2.65909160 |
| 54 | Peritonitis (HP:0002586) | 2.65544488 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.59175128 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.52538244 |
| 57 | Abnormality of T cells (HP:0002843) | 2.52224432 |
| 58 | Loss of speech (HP:0002371) | 2.49217723 |
| 59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46723193 |
| 60 | Gastrointestinal inflammation (HP:0004386) | 2.40634475 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40285120 |
| 62 | Granulocytopenia (HP:0001913) | 2.35195199 |
| 63 | Abnormality of the pleura (HP:0002103) | 2.28432645 |
| 64 | Purpura (HP:0000979) | 2.27104726 |
| 65 | Increased IgM level (HP:0003496) | 2.24595861 |
| 66 | Osteomyelitis (HP:0002754) | 2.21817192 |
| 67 | Petechiae (HP:0000967) | 2.21689214 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.21666644 |
| 69 | Increased serum ferritin (HP:0003281) | 2.20521385 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.20331733 |
| 71 | Dysostosis multiplex (HP:0000943) | 2.19385909 |
| 72 | Colitis (HP:0002583) | 2.16343124 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.13641799 |
| 74 | Microcytic anemia (HP:0001935) | 2.13345391 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.13228533 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 2.09260579 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.09132514 |
| 78 | Abnormality of the peritoneum (HP:0002585) | 2.05647046 |
| 79 | Glomerulopathy (HP:0100820) | 2.05391901 |
| 80 | Eosinophilia (HP:0001880) | 2.04488974 |
| 81 | Abnormality of the endocardium (HP:0004306) | 2.04095497 |
| 82 | Polyneuropathy (HP:0001271) | 2.03837738 |
| 83 | Joint swelling (HP:0001386) | 2.03245892 |
| 84 | Sepsis (HP:0100806) | 2.03200740 |
| 85 | Acne (HP:0001061) | 2.02918901 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.02819424 |
| 87 | Thrombophlebitis (HP:0004418) | 2.01551091 |
| 88 | Slow saccadic eye movements (HP:0000514) | 2.00208183 |
| 89 | Vertigo (HP:0002321) | 1.99463430 |
| 90 | Acute hepatic failure (HP:0006554) | 1.95361724 |
| 91 | Lymphopenia (HP:0001888) | 1.92120939 |
| 92 | Keratitis (HP:0000491) | 1.91324088 |
| 93 | Hematochezia (HP:0002573) | 1.88451109 |
| 94 | Skin ulcer (HP:0200042) | 1.87343468 |
| 95 | Disinhibition (HP:0000734) | 1.87142968 |
| 96 | Abnormality of the pericardium (HP:0001697) | 1.83930485 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83469639 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83469639 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83469639 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82719584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.30513435 |
| 2 | MAP4K1 | 3.40485674 |
| 3 | BLK | 2.99624958 |
| 4 | TYK2 | 2.91303316 |
| 5 | MAP2K3 | 2.88191783 |
| 6 | ERN1 | 2.84103850 |
| 7 | IRAK4 | 2.81915672 |
| 8 | PRPF4B | 2.59909643 |
| 9 | CSK | 2.55594713 |
| 10 | FES | 2.31015512 |
| 11 | ZAP70 | 2.12204117 |
| 12 | MAP3K14 | 2.11863980 |
| 13 | GRK6 | 2.08171838 |
| 14 | TXK | 1.94841898 |
| 15 | TAOK3 | 1.85043744 |
| 16 | TNK2 | 1.84970071 |
| 17 | JAK3 | 1.83739647 |
| 18 | EPHB1 | 1.76443126 |
| 19 | MAP3K3 | 1.75641149 |
| 20 | FGR | 1.75464684 |
| 21 | TAOK1 | 1.74190568 |
| 22 | IKBKE | 1.71582557 |
| 23 | BTK | 1.66452854 |
| 24 | SYK | 1.63872282 |
| 25 | HCK | 1.63515571 |
| 26 | MAP3K13 | 1.61103922 |
| 27 | TBK1 | 1.58013159 |
| 28 | JAK1 | 1.48545029 |
| 29 | JAK2 | 1.43409354 |
| 30 | MAP3K11 | 1.42616834 |
| 31 | MAP3K1 | 1.36292468 |
| 32 | LYN | 1.34338514 |
| 33 | CSF1R | 1.31228637 |
| 34 | MATK | 1.24775257 |
| 35 | IRAK3 | 1.23502457 |
| 36 | ITK | 1.23356306 |
| 37 | IRAK1 | 1.19912172 |
| 38 | LCK | 1.17469426 |
| 39 | YES1 | 1.17222981 |
| 40 | KIT | 1.16641873 |
| 41 | KSR2 | 1.15200528 |
| 42 | PIK3CG | 1.10451101 |
| 43 | IKBKB | 1.10154908 |
| 44 | TAOK2 | 1.07768345 |
| 45 | TGFBR2 | 1.05476223 |
| 46 | BMPR2 | 1.04066905 |
| 47 | MARK3 | 1.03291077 |
| 48 | TEC | 0.97002835 |
| 49 | IRAK2 | 0.95951186 |
| 50 | PDK1 | 0.94609194 |
| 51 | STK10 | 0.93079730 |
| 52 | MARK2 | 0.92208109 |
| 53 | MAP3K2 | 0.90269382 |
| 54 | GRK7 | 0.88861359 |
| 55 | SIK3 | 0.86960317 |
| 56 | FGFR3 | 0.83870476 |
| 57 | MAP3K6 | 0.83020108 |
| 58 | PDPK1 | 0.81056770 |
| 59 | NLK | 0.70307899 |
| 60 | PTK6 | 0.68272539 |
| 61 | MAPK12 | 0.68127986 |
| 62 | PRKD2 | 0.66771599 |
| 63 | MAP3K5 | 0.66504060 |
| 64 | SGK3 | 0.65314169 |
| 65 | CDC42BPA | 0.64968857 |
| 66 | LRRK2 | 0.64476326 |
| 67 | EPHA3 | 0.64334144 |
| 68 | MAPK7 | 0.64044221 |
| 69 | FGFR4 | 0.63704600 |
| 70 | MAP2K6 | 0.63342568 |
| 71 | TRIB3 | 0.61278071 |
| 72 | PIM1 | 0.58947231 |
| 73 | MAP3K7 | 0.57848868 |
| 74 | ACVR1B | 0.56644952 |
| 75 | MAP2K4 | 0.56585794 |
| 76 | DYRK1B | 0.56201410 |
| 77 | CAMKK2 | 0.55260153 |
| 78 | FYN | 0.55189223 |
| 79 | HIPK2 | 0.55109158 |
| 80 | SGK2 | 0.55057744 |
| 81 | PRKCQ | 0.54722596 |
| 82 | DAPK2 | 0.51151697 |
| 83 | RPS6KC1 | 0.49025053 |
| 84 | RPS6KL1 | 0.49025053 |
| 85 | PTK2B | 0.48226331 |
| 86 | SIK2 | 0.48201265 |
| 87 | STK11 | 0.47337546 |
| 88 | CDK19 | 0.46348287 |
| 89 | RPS6KA6 | 0.43128085 |
| 90 | MOS | 0.40595079 |
| 91 | RET | 0.39618289 |
| 92 | CDK6 | 0.38234379 |
| 93 | RAF1 | 0.37684993 |
| 94 | CHUK | 0.36099242 |
| 95 | RIPK1 | 0.35463046 |
| 96 | MAPKAPK2 | 0.33936543 |
| 97 | TESK2 | 0.33794502 |
| 98 | CAMKK1 | 0.33583366 |
| 99 | STK38 | 0.32547183 |
| 100 | STK24 | 0.32254343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.21308152 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05422654 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.98396893 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.36895313 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.36460646 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23072229 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.20111991 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.13370189 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.11103068 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08591609 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04315881 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98043952 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.92167346 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83300531 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80699799 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.79937362 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.77509162 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.75278305 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71912791 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.67414324 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63314808 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62187775 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61904327 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57932901 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57852856 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.55951142 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54981934 |
| 28 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51799257 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51149819 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49971220 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44315314 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42294991 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38731269 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.38291618 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.34337157 |
| 36 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33033990 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.32651515 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32208225 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30561690 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24140940 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21944971 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20016609 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.12468292 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.10012703 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.09681661 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06530325 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04923208 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.04583757 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02923333 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.94892229 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94479719 |
| 52 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92889160 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88192821 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.87803905 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85183675 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84298548 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83991110 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80450883 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79373914 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.78494902 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78298071 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74643294 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73579921 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70074791 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68320065 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67601849 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.66642265 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66124991 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.65479537 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64269776 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64134173 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60165267 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.54255437 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53936235 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51809395 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50977323 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50598998 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50276529 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48663563 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48334435 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48257794 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46807563 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46193627 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44881961 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44199104 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44010642 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43734992 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42896097 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42281915 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38830082 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38342932 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35929030 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35135072 |
| 94 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33985766 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33386074 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.31809491 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31590481 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.27610694 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27244165 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25895088 |

